Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The combination of salbutamol and Viola odorata flower syrup is an adjuvant therapeutic regimen used primarily for the treatment of cough in pediatric patients with intermittent asthma. Salbutamol, a short-acting beta-2 adrenergic agonist (SABA), provides rapid bronchodilation by relaxing airway smooth muscle. The Viola odorata component, often administered as Banafsheh Syrup, is a traditional herbal preparation containing an aqueous extract of sweet violet flowers. Clinical studies, particularly in Iran, have shown that the addition of violet syrup to standard salbutamol therapy significantly improves cough suppression and reduces the duration of symptoms compared to salbutamol alone. The herbal component is thought to provide complementary anti-inflammatory and antitussive effects, enhancing the overall efficacy of the respiratory treatment.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on salbutamol + viola odorata flower syrup.